Symptomatic respiratory virus infection and chronic lung allograft dysfunction

Clinical Infectious Diseases

Volumn 62, Issue 3, 2016, Pages 313-319

  Fisher, Cynthia E ^a,b   Preiksaitis, Carl M ^a   Lease, Erika D ^a   Edelman, Jeffrey ^a   Kirby, Katharine A ^a   Leisenring, Wendy M ^b   Raghu, Ganesh ^a   Boeckh, Michael ^a,b   Limaye, Ajit P ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

Author keywords

bronchiolitis obliterans; chronic lung allograft dysfunction; lung transplantation; respiratory virus infection; restrictive allograft dysfunction

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC LUNG ALLOGRAFT DYSFUNCTION; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RESPIRATORY VIRUS INFECTION; VIRUS INFECTION; ADOLESCENT; ALLOGRAFT; COMPLICATION; GRAFT REJECTION; MIDDLE AGED; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLOGRAFTS; FEMALE; GRAFT REJECTION; HOSPITALS, UNIVERSITY; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; TRANSPLANT RECIPIENTS; VIRUS DISEASES; YOUNG ADULT;

EID: 84962250930     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ871     Document Type: Article

References (35)

1. Sato M, Waddell TK, Wagnetz U., et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30: 735-42
2. Khalifah AP, Hachem RR, Chakinala MM., et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004; 170: 181-7
3. Kroshus TJ, Kshettry VR, Savik K, John R, Hertz MI, Bolman RM. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997; 114: 195-202
4. Meyer KC, Glanville AR. Bronchiolitis obliterans syndrome in lung transplantation. New York: Springer, 2013
5. Yusen RD, Christie JD, Edwards LB., et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report-2013; focus theme: age. J Heart Lung Transplant 2013; 32: 965-78
6. Magnusson J, Westin J, Andersson LM, Brittain-Long R, Riise GC. The impact of viral respiratory tract infections on long-Term morbidity and mortality following lung transplantation: a retrospective cohort study using a multiplex PCR panel. Transplantation 2013; 95: 383-8
7. Gottlieb J, Schulz TF, Welte T., et al. Community-Acquired respiratory viral infections in lung transplant recipients: a single season cohort study. Transplantation 2009; 87: 1530-7
8. Milstone AP, Brumble LM, Barnes J., et al. A single-season prospective study of respiratory viral infections in lung transplant recipients. Eur Respir J 2006; 28: 131-7
9. Billings JL, Hertz MI, Savik K, Wendt CH. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transplant 2002; 21: 559-66
10. Bridges ND, Spray TL, Collins MH, Bowles NE, Towbin JA. Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg 1998; 116: 617-23
11. Vu DL, Bridevaux PO, Aubert JD, Soccal PM, Kaiser L. Respiratory viruses in lung transplant recipients: a critical review and pooled analysis of clinical studies. Am J Transplant 2011; 11: 1071-8
12. Stewart S, Fishbein MC, Snell GI., et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26: 1129-42
13. Kuypers J, Wright N, Morrow R. Evaluation of quantitative and type-specific realtime RT-PCR assays for detection of respiratory syncytial virus in respiratory specimens from children. J Clin Virol 2004; 31: 123-9
14. Kuypers J, Wright N, Corey L, Morrow R. Detection and quantification of human metapneumovirus in pediatric specimens by real-Time RT-PCR. J Clin Virol 2005; 33: 299-305
15. Kuypers J, Wright N, Ferrenberg J., et al. Comparison of real-Time PCR assays with fluorescent-Antibody assays for diagnosis of respiratory virus infections in children. J Clin Microbiol 2006; 44: 2382-8
16. Kuypers J, Martin ET, Heugel J, Wright N, Morrow R, Englund JA. Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics 2007; 119: e70-6
17. Lu X, Holloway B, Dare RK., et al. Real-Time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses. J Clin Microbiol 2008; 46: 533-9
18. Kuypers J, Campbell AP, Cent A, Corey L, Boeckh M. Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients. Transpl Infect Dis 2009; 11: 298-303
19. Verleden GM, Raghu G, Meyer KC, Glanville AR, Corris P. A new classification system for chronic lung allograft dysfunction. J Heart Lung Transplant 2014; 33: 127-33
20. Todd JL, Jain R, Pavlisko EN., et al. Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction. Am J Respir Crit Care Med 2014; 189: 159-66
21. Estenne M, Maurer JR, Boehler A., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310
22. Weigt SS, Copeland CA, Derhovanessian A., et al. Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a twocenter validation study. Am J Transplant 2013; 13: 919-27
23. Botha P, Archer L, Anderson RL., et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 2008; 85: 771-4
24. Gregson AL, Wang X, Weigt SS., et al. Interaction between pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation. Am J Respir Crit Care Med 2013; 187: 518-26
25. Palmer SM, Henshaw NG, Howell DN, Miller SE, Davis RD, Tapson VF. Community respiratory viral infection in adult lung transplant recipients. Chest 1998; 113: 944-50
26. Vilchez RA, McCurry K, Dauber J., et al. The epidemiology of parainfluenza virus infection in lung transplant recipients. Clin Infect Dis 2001; 33: 2004-8
27. Hopkins P, McNeil K, Kermeen F., et al. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med 2008; 178: 876-81
28. Larcher C, Geltner C, Fischer H, Nachbaur D, Müller LC, Huemer HP. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J Heart Lung Transplant 2005; 24: 1891-01
29. Kumar D, Husain S, Chen MH., et al. A prospective molecular surveillance study evaluating the clinical impact of community-Acquired respiratory viruses in lung transplant recipients. Transplantation 2010; 89: 1028-33
30. Angaswamy N, Tiriveedhi V, Sarma NJ., et al. Interplay between immune responses to HLA and non-HLA self-Antigens in allograft rejection. Hum Immunol 2013; 74: 1478-85
31. Weigt SS, Derhovanessian A, Liao E., et al. CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction. Am J Transplant 2012; 12: 477-84
32. Zamora MR, Budev M, Rolfe M., et al. RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med 2011; 183: 531-8
33. Moss RB, Hansen C, Sanders RL, Hawley S, Li T, Steigbigel RT. A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection. J Infect Dis 2012; 206: 1844-51
34. Guzmán-Suarez BB, Buckley MW, Gilmore ET., et al. Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients. Transpl Infect Dis 2012; 14: 427-33
35. DeVincenzo J, Lambkin-Williams R, Wilkinson T., et al. A randomized, doubleblind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci U S A 2010; 107: 8800-5